Ranbaxy launches acne drug in US

Source : REUTERS
Last Updated: Mon, Nov 26, 2012 08:25 hrs
Ranbaxy CEO quits, cites strategy rift

Ranbaxy Laboratories Ltd , India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.

The drug is in-licensed from Cipher Pharmaceuticals Inc , said Ranbaxy, controlled by Japan's Daiichi Sankyo Co <4568.T>, on Monday.

More from Sify: